BLINCYTO® is a prescription medicine used to treat adults and children 1 month and older with:
B-cell precursor acute lymphoblastic leukemia (ALL) in remission when only a small number of cancer cells remain in the body (minimal residual disease)...read more
BLINCYTO® is a prescription medicine used to treat adults and children 1 month and older with:
B-cell precursor acute lymphoblastic leukemia (ALL) in remission when only a small number of cancer cells remain in the body (minimal residual disease)...read more
B-cell precursor ALL that has come back or did not respond to previous treatments
Philadelphia-chromosome negative B cell precursor ALL in the consolidation phase of chemotherapy treatment with multiple phases
ALL is a cancer of the blood in which a particular kind of white blood cell is growing out of control.It is not known if BLINCYTO is safe and effective in children less than 1 month of age.
